Study of antidepressant arrhythmia risks proves value of EHRs

02/4/2013 | Government Health IT online

Massachusetts General Hospital researchers used EHR data in a study that supported FDA warnings regarding risk of arrhythmia in patients using the antidepressant citalopram. Pulling data from EHRs was more efficient than working with patient charts, researchers said, saving time while safeguarding patient privacy. "We only extract the data we need and never see anything that would allow us to identify an individual patient," said Dr. Roy Perlis, co-author of the study.

View Full Article in:

Government Health IT online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX